Wed, 12/14/2022 - 07:06 |
GT Biopharma Names Dr. Jeff Miller as Consulting Chief Medical Officer |
Oxis Biotech |
Tue, 12/13/2022 - 11:24 |
Blinatumomab further improves survival among B-lineage ALL patients with a good prognosis |
American Societ... |
Tue, 12/13/2022 - 10:51 |
Next-Generation Drug Improves Progression-Free Survival in Relapsed Chronic Lymphocytic Leukemia |
Dana Farber |
Mon, 12/12/2022 - 16:00 |
City of Hope Study Finds That Neuroendocrine Cancer Patients and Doctors Agree on Treatment Goals Only Half of the Time |
City of Hope Na... |
Thu, 12/08/2022 - 16:30 |
USPTO announces Cancer Moonshot Expedited Examination Pilot Program |
USPTO |
Wed, 12/07/2022 - 19:12 |
IMV Shareholders Approve Reverse Stock Split at 88% |
Immunovaccine |
Wed, 12/07/2022 - 10:59 |
Fox Chase Researcher Receives American Cancer Society Grant to Study Synthetic Targets for Tumor Drug Delivery |
Fox Chase Cance... |
Fri, 12/02/2022 - 11:03 |
Two Fox Chase Clinicians Named to 2022 List of Worlds Most Highly Cited Researchers |
Fox Chase |
Thu, 12/01/2022 - 05:00 |
Wistars Hubert J.P. Schoemaker Education and Training Center Receives National Science Foundation REU Grant |
Wistar Institute |
Wed, 11/30/2022 - 18:43 |
New Treatment Strategy Could Boost Efficacy of Immunotherapy in Patients With Solid Tumors |
Roswell Park Ca... |
Wed, 11/23/2022 - 14:09 |
World first clinical trial in 'man's best friend' could unlock treatment breakthrough for kids with cancer |
UWA |
Mon, 11/21/2022 - 14:27 |
City of Hope Study Finds Medicare Advantage May Put Complex Cancer Surgery Patients at a Disadvantage |
City of Hope Na... |
Mon, 11/21/2022 - 06:23 |
Lung Cancer Awareness Month Highlights Importance of Preventive Screenings |
American Lung A... |
Thu, 11/17/2022 - 15:58 |
Ludwig Cancer Research study finds common, targetable mechanism tumors use to suppress immune responses |
Ludwig Cancer R... |
Mon, 11/14/2022 - 16:21 |
IASLC Names Four Multidisciplinary International Doctors as Co-Chairs of IASLC 2024 World Conference on Lung Cancer |
IASLC |
Thu, 11/10/2022 - 14:19 |
CAR T-Cell Therapy Outcomes Similar Across Different Socioeconomic Levels |
American Societ... |
Tue, 11/08/2022 - 10:56 |
American Brain Tumor Association Awards 20 Research Grants to Advance Brain Tumor Science and Discoveries |
American Brain ... |
Thu, 11/03/2022 - 10:23 |
Gilead and Kite Oncology Demonstrate Transformative Impact of Cell Therapy and Promise of Blood Cancer Portfolio at ASH 2022 |
Gilead Sciences |
Wed, 11/02/2022 - 19:57 |
New UArizona Health Sciences center receives $150M state investment |
ArizonaUniv |
Tue, 11/01/2022 - 14:56 |
Nascent Biotech Receives Notice of the Issuance of US Patent No.11,494,394 |
Nascent Biotech |
Tue, 11/01/2022 - 10:37 |
IASLC Position Statement on Tobacco Cessation After a Cancer Diagnosis |
IASLC |
Tue, 11/01/2022 - 09:37 |
Ashley and City of Hope launch campaign to raise awareness for National Diabetes Month |
City of Hope Na... |
Mon, 10/31/2022 - 00:00 |
Artificial Intelligence Approach May Help Identify Melanoma Survivors Who Face A High Risk of Cancer Recurrence |
Massachusetts G... |
Thu, 10/27/2022 - 17:51 |
Ludwig Chicago nanotechnology induces therapeutic immune responses against multiple types of tumors in preclinical studies |
Ludwig Cancer R... |
Thu, 10/27/2022 - 14:29 |
Why immunotherapy works well for some cancer patients, but not others |
YaleUniversity |